Multiple Myeloma in Mexico: A 20-year experience at a single institution

Archives of Medical Research

Volumn 35, Issue 2, 2004, Pages 163-167

  Ruiz Argüelles, Guillermo J ^a,b   Gómez Rangel, J David ^a,b   Ruiz Delgado, Guillermo J ^c   Aguilar Romero, Leticia ^b  

^a CENTRO DE HEMATOLOGÍA Y MEDICINA INTERNA DE PUEBLA   (Mexico)

^b Laboratorios Clinicos de Puebla   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Autograft; Mexico; Multiple myeloma; Prevalence; Treatment

Indexed keywords

BENCE JONES PROTEIN; DEXAMETHASONE; DOXORUBICIN; HEMOGLOBIN; MELPHALAN; PREDNISONE; VINCRISTINE;

ADULT; AGED; ANEMIA; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE PAIN; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CAUCASIAN; CLINICAL FEATURE; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FATIGUE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; MULTIPLE MYELOMA; SEX RATIO; SYMPTOM; WEIGHT REDUCTION;

ADULT; AGED; FEMALE; HUMANS; MALE; MEXICO; MIDDLE AGED; MULTIPLE MYELOMA; TIME FACTORS;

EID: 1542328917     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2003.09.013     Document Type: Article

References (20)

1. Kyle R.A., Gertz M.A., Witzig T.E., Lust J.A., Lacy M.Q., Dispenzieri A., Fonseca R., Rajkumar S.V., Offord J.R., Larson D.R., Plevak M.E., Therneau T.M., Greipp P.R. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 78:2003;21-33.
2. Ruiz-Argüelles G.J., Cantú-Rodríguez O.G., Mercado-Díaz L., Apreza-Molina G., Gómez-Almaguer D., Cortés-Franco J., Góngora-Biachi R.A., Pizzuto J., Rodríguez-Carrillo J., Romero-García F., Torre-López E., Vázquez-Villegas V. Some chronic lymphoproliferative malignancies in Mexico are less frequent than in Caucasian populations. Blood. 88:(Suppl 1):1996;217b.
3. National Center for Health Statistics. Vital Statistics of the United States, 1988. Mortality, Part A. 1991;Public Health Service, Washington, D.C., USA.
4. Kyle R.A. Long-term survival in multiple myeloma. N Engl J Med. 308:1983;314-316.
5. Kumar S., Gertz M.A., Dispenzieri A., Lacy M.Q., Geyer S.M., Iturria N.L., Fonseca R., Hayman S.R., Lust J.A., Kyle R.A., Greipp P.R., Witzing T.E., Rajkumar S.V. Response rate, durability of response and survival after thalidomide therapy for relapsed multiple myeloma. Mayo Clin Proc. 78:2003;34-39.
6. Ruiz-Reyes G., Ruiz-Argüelles A. Padecimientos inmunoproliferativos malignos. Ruiz-Argüelles G.J. Fundamentos de hematologia. 3rd ed. 2003;322-341 Editorial Médica Panamericana, México.
7. Myeloma Trialist Collaborative Group. Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6633 patients from 27 randomized trials. J Clin Oncol. 16:1998;3832-3842.
8. Segeren C.M., Sonneveld P., van der Holt B., Baars J.W., Biesma D.H., Cornellissen J.J., Croockewit A.J., Dekker A.W., Fibbe W.E., Lowenberg B., van Marwijk Kooy M., van Oers M.H., Richel D.J., Schouten H.C., Vellenga E., Verhoef G.E., Wijermans P.W., Wittebol S., Lokhorst H.M. Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma. Br J Haematol. 105:1999;127-130.
9. Rajkumar S.V., Hayman S., Gertz M.A., Dispenzieri A., Lacy M.Q., Greipp P.R., Geyer S., Iturria N., Fonseca R., Lust J.A., Kyle R.A., Witzig T.E. Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma. J Clin Oncol. 20:2002;4319-4323.
10. Ruiz-Argüelles G.J., Ruiz-Argüelles A., Pérez-Romano B., Marín-López A., Delgado-Lamas J.L. Non-cryopreserved peripheral blood stem cells autotransplants for hematological malignancies can be performed entirely on an outpatient basis. Am J Hematol. 58:1998;161-164.
11. Ruiz-Argüelles G.J., Lobato-Mendizábal E., Ruiz-Argüelles A., Pérez-Romano B., Arizpe-Bravo D., Marín-López A. Non-cryopreserved unmanipulated hematopoietic peripheral blood stem cell autotransplant program: long-term results. Arch Med Res. 30:1999;380-384.
12. Durie B.G., Salmon S.E. A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer. 36:1975;842-854.
13. Ruiz-Argüelles G.J., Gómez-Rangel J.D. Trasplante autólogo en mieloma múltiple: utilidad de la talidomida en el período post-trasplante. (abstract) Rev Hematol. 4:2003;24.
14. Ruiz-Argüelles G.J., Ramírez-Cisneros F.J., Flores-Martínez J., Cernuda-Graham M.C. Waldenström's macroglobulinemia is infrequent in Mexican mestizos: experience of a hematological diseases referral center. Rev Invest Clin (Mex). 52:2000;497-499.
15. Ruiz-Delgado G.J., Gómez-Rangel D. Monoclonal gammopathy of undetermined significance: a single institution experience. Gac Med Mex. 2004;. in press.
16. Ruiz-Reyes G., Landero-de-Ruiz N., Armenta-Olvera T., Sánchez-Fernández M., Pérez-de-Sánchez C.L., Gamboa-Ojeda I. Gamopatías monoclonales I. Distribución de clases y tipos de cadenas pesadas y ligeras en 182 casos. Rev Invest Clin (Mex). 30:1978;359-365.
17. Ruiz-Argüelles G.J., Velázquez B.M., Apreza-Molina M.G., Pérez-Romano B., Ruiz-Reyes G., Ruiz-Argüelles A. Chronic lymphocytic leukemia is infrequent in Mexican mestizos. Int J Hematol. 69:1999;253-255.
18. Lobato-Mendizábal E., López-Martínez B., Ruiz-Argüelles G.J. A critical review of the prognostic value of the nutritional status at diagnosis in the outcome of therapy of children with acute lymphoblastic leukemia. Rev Invest Clin. 55:2003;31-35.
19. Alexanian R., Dimopoulos M. The treatment of multiple myeloma. N Engl J Med. 330:1994;484-489.
20. Anderson K.C. Multiple myeloma: how far have we come? Mayo Clin Proc. 78:2003;15-17.